Ticker brief
TMO THERMO FISHER SCIENTIFIC INC
Consumer, Non-cyclical · Healthcare-Products
last close
$673.82
1 day
-0.4%
14 days
+2.4%
mkt cap
$194.5B
signals 14d
21
authors 14d
16
crowd 14d
-0.2σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 32% mid · 58 pctile own 1y | IV/HV 1.05× |
| Skew — 25Δ RR 30d | -0.030 52 pctile own 1y | balanced vs own range |
| Net dealer OI (NDOI) | +0.26 normal | 5-session Δ +0.08 (as of 2026-07-16) |
| OI alarm | quiet | last alarm 2025-10-22 (z=2.3) |
Sentiment — last 14 days
daily mean sentiment, 2026-10-04 → 2026-10-14 · now +0.00 (−1 bearish … +1 bullish)
Who spoke16
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @TheNewMoney_app | C | · | 3 | +0.47 |
| @Benzinga | C | +0.17 | 2 | +0.13 |
| @DividendTalks | C | +1.41 | 2 | +0.30 |
| @VictorG_bolsa | C | -0.08 | 2 | +0.20 |
| @GutierrezRom | C | -0.59 | 1 | +0.40 |
| @tradealgo_ | C | +1.91 | 1 | +0.60 |
| @benitoz | B | -2.30 | 1 | +0.55 |
| @CHItrader | B | -0.22 | 1 | +0.20 |
| @theflynews | C | · | 1 | +0.10 |
| @newsinvesting | C | · | 1 | +0.35 |
| @SixSigmaCapital | B | +0.16 | 1 | +0.40 |
| @MarkNewtonCMT | B | -0.57 | 1 | +0.55 |
| @artinmemes | C | +1.04 | 1 | +0.35 |
| @AnthonySandford | C | · | 1 | +0.00 |
| @_TP888 | C | +0.93 | 1 | -0.55 |
| @Kalshi_Finance | · | -1.98 | 1 | +0.00 |
Recent signals21of 21 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-14 | @VictorG_bolsa | +0.00 | Presents a multi-sector stock watchlist without entry intent or directional views. | +0.1% | tweet ↗ |
| 2026-10-13 | @TheNewMoney_app | +0.35 | Reports a purchase of TMO $800 calls. | +1.6% | tweet ↗ |
| 2026-10-10 | @Kalshi_Finance | +0.00 | Identifies three companies scheduled to report earnings next week. | +2.4% | tweet ↗ |
| 2026-10-09 | @DividendTalks | +0.40 | Reports six of JPMorgan's explicitly bullish stock selections. | +2.4% | tweet ↗ |
| 2026-10-08 | @TheNewMoney_app | +0.40 | Reports a large purchase of TMO $780 calls expiring January 19, 2029. | +3.3% | tweet ↗ |
| 2026-10-08 | @_TP888 | -0.55 | Reports $385K of aggressive TMO put buying. | +3.3% | tweet ↗ |
| 2026-10-08 | @AnthonySandford | +0.00 | Lists the largest $10M-plus dark-pool prints and cautions they are levels, not automatic directions. | +3.3% | tweet ↗ |
| 2026-10-08 | @artinmemes | +0.35 | The author presents a bullish basket of life-science suppliers positioned around the AI-drug-discovery bottleneck. | +3.3% | tweet ↗ |
| 2026-10-07 | @MarkNewtonCMT | +0.55 | Sees compelling intermediate-term life-sciences breakouts despite near-term TMO consolidation risk. | +1.8% | tweet ↗ |
| 2026-10-07 | @VictorG_bolsa | +0.40 | Lists favored industries and representative stocks for a three-month horizon. | +1.8% | tweet ↗ |
| 2026-10-06 | @Benzinga | +0.15 | Thermo Fisher will support Quantum Biopharma's multiple-sclerosis drug trial. | +2.6% | tweet ↗ |
| 2026-10-06 | @DividendTalks | +0.19 | Lists Wall Street's projected 2027 upside for eight stocks and asks readers to choose one. | +2.6% | tweet ↗ |
| 2026-10-06 | @TheNewMoney_app | +0.65 | Reports a $528,700 purchase of long-dated TMO $840 calls. | +2.6% | tweet ↗ |
| 2026-10-06 | @SixSigmaCapital | +0.40 | Explicitly states a favorable opinion of TMO. | +2.6% | tweet ↗ |
| 2026-10-06 | @newsinvesting | +0.35 | Thermo Fisher reached an all-time high of $684.10. | +2.6% | tweet ↗ |
| 2026-10-06 | @theflynews | +0.10 | Quantum BioPharma signed a contract with Thermo Fisher for a sclerosis trial. | +2.6% | tweet ↗ |
| 2026-10-06 | @CHItrader | +0.20 | Thermo Fisher's PPD will support QNTM's Phase 2 Lucid-MS trial after FDA clearance. | +2.6% | tweet ↗ |
| 2026-10-06 | @Benzinga | +0.10 | Quantum BioPharma contracted Thermo Fisher's clinical-research business for a Phase 2 trial. | +2.6% | tweet ↗ |
| 2026-10-05 | @benitoz | +0.55 | Presents a 20-name AI-biology research basket; ticker cap preserves input order. | -0.4% | tweet ↗ |
| 2026-10-05 | @tradealgo_ | +0.60 | Retrospective bullish-model gain of 39.44% over 119 days. | -0.4% | tweet ↗ |
| 2026-10-04 | @GutierrezRom | +0.40 | JPMorgan adds AXP, LBRT, and TMO as October top ideas rated Overweight. | +2.9% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.